Abstract Details

Title Evaluating Implementation of an EHR-enabled Alzheimer’s Disease Care Pathway in Primary Care to Enhance Assessment and Detection Practices

Topic Aging, Dementia, and Behavioral Neurology

Presentation(s) P4 - Poster Session 4 (8:00 AM-9:00 AM)

Poster/Presentation
Number 12-002

Objective This initiative seeks to evaluate the implementation of an electronic health record (EHR) enabled Alzheimer’s disease (AD) care pathway and AD assessment and detection practice outcomes.

Background The 2025 Alzheimer’s Association Special Report indicated that nearly 80% of Americans want to know if they had AD before experiencing symptoms or prior to symptoms interfering with daily activities. While a brief cognitive assessment (CA) is a required component of the Medicare Annual Wellness Visit (AWV), PCP CA practices remain suboptimal, with 58% of surveyed PCPs citing time constraints as a barrier. To streamline workflows and measure AD assessment practices, Midwestern University, Corewell Health, and Tufts Medicine implemented EHR-enabled AD care pathways in primary care settings.

Design/Methods In October 2025, all sites began implementing EHR-integrated cognitive screening tests (MoCA, Mini-Cog, MMSE, or the SLUMS) with auto-score features, for patients presenting with cognitive concerns or during AWVs. Tools to enhance further cognitive evaluation include an OPA (“our practice advisory”) and a cognitive impairment SmartSet. Primary endpoints include number of eligible patients that receive a CA, number with an abnormal CA score, and number receiving further workup, including labs, imaging, and referrals.

Results Baseline data pre-implementation across three sites over 6 months indicates that 18% of eligible patients received a CA; of those, 18.6% received an abnormal screening score, and 13% had lab testing completed within the last 6 months to rule out reversible causes of cognitive impairment. Ultimately, 0.25% of eligible patients during the baseline period received a new AD diagnosis code (G30.0, G30.1, G30.8, G30.9).

Conclusions Baseline data highlights gaps in use of CA for eligible patients in primary care, and reinforces the need for continued education and standardized, EHR-integrated workflows. Future analyses will evaluate active study period data and changes relative to baseline.

Authors/Disclosures
Kimberly Huntington-Alfano, DO PRESENTER	Dr. Huntington-Alfano has nothing to disclose.
Amita Pai, MD	Dr. Pai has nothing to disclose.
Holly Jain, MD	Dr. Jain has received personal compensation for serving as an employee of Petauri Kinect.
Sarah Gallant (Brain Health Leaders Network)	No disclosure on file
Cecilia McAlear	Ms. McAlear has nothing to disclose.
Dennis J. Rivet, Sr.	Dr. Rivet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Rivet has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Toenges Ventures LLC. The institution of Dr. Rivet has received research support from NCS-01.
Raeanne C. Moore, PhD	The institution of Dr. Moore has received research support from NIH.
Kylie Prehn, DO	Dr. Prehn has nothing to disclose.
brent forester, MD	Dr. forester has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CVS Health. Dr. forester has stock in Rippl Care. Dr. forester has stock in Patina Health.

��ɫ��

��ɫ��